CIO Influence News Regulation and Compliance ManagmentVaxart Granted Extension by Nasdaq to Regain ComplianceGlobeNewswireAugust 29, 2025 by GlobeNewswireAugust 29, 20250 Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, announced that it received a decision...